SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Mazzarella who wrote (1446)2/2/1997 3:49:00 PM
From: richard davis   of 4342
 
Richard:

If Paracelsian issues a press release the same day as the SB conference, I believe they will be in full compliance with the SEC laws. So whats the big deal? Lets not make things complicated for them. We have ALL been waiting a long time to hear the future of paracelsian and their products, lets not nitpick them on this point.

Robin: Good question. I was rumming around the SI thread one day, and i read another biotech is having the same problem with DOW. I wonder what DOW's problem is?

Along that same lines, I re-read the 10K, and I wish they would focus on things like AndroVir and Androcar and drop things like the vetinary cancer test package. They need to focus like a laser on those profitable products and stop worrying about these little products. I would also like to see them some day develop those other compounds like the anti-coagulant pn 27,1, and the other compounds which i can't think of right now (sunday brain dead day).

Paul are you noting all these questions, or should I summarize them for you?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News